Phathom Pharmaceuticals, Inc. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Phathom Pharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2024.
  • Phathom Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $200K, unchanged year-over-year.
  • Phathom Pharmaceuticals, Inc. annual Operating Lease, Payments for 2023 was $1.1M, unchanged from 2022.
  • Phathom Pharmaceuticals, Inc. annual Operating Lease, Payments for 2022 was $1.1M, a 57.1% increase from 2021.
  • Phathom Pharmaceuticals, Inc. annual Operating Lease, Payments for 2021 was $700K, a 22.2% decline from 2020.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $200K $0 0% Jan 1, 2024 Mar 31, 2024 10-Q/A 2024-06-14
Q1 2023 $200K +$100K +100% Jan 1, 2023 Mar 31, 2023 10-Q/A 2024-06-14
Q1 2022 $100K -$100K -50% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q1 2021 $200K -$100K -33.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q1 2020 $300K +$300K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q1 2019 $0 Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.